论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Guo F, Zhang ZY, Cui YS, Li L, Xu XH, Li SQ
Received 21 July 2017
Accepted for publication 28 October 2017
Published 29 November 2017 Volume 2017:13 Pages 1543—1549
DOI https://doi.org/10.2147/TCRM.S146977
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Hoa Le
Peer reviewer comments 2
Editor who approved publication: Professor Deyun Wang
Introduction: Acquired
benign esophageal tracheobronchial fistulae are clinically rare. In this paper,
we summarize our experiences in surgical treatment of 14 consecutive patients
with acquired benign esophageal tracheobronchial fistula.
Methods: This series included patients who underwent surgery between
January 2002 and June 2015 at our institution. We retrieved and analyzed data
on demographics, operative characteristics, and surgical outcome of the
patients.
Results: Bronchofiberscopy revealed the membranous trachea openings of
fistulae and gastroendoscopy further showed lesions in the anterolateral wall
of the esophagus. Thoracotomy, division of the fistulous tract, and closure of
the esophagus and trachea and other procedures were performed. All operations
were uneventful, and there was no perioperative and postoperative complication
or death. Symptoms disappeared after surgery in patients. The median length of
hospital stay was 53 (range 31–270) days. The patients were followed up for a
median of 33.5 (range 15–168) months. No recurrence was reported.
Conclusion: Our results suggest that acquired benign esophageal tracheobronchial
fistulae have a broad spectrum of anatomic pathologies and exhibit markedly
varied clinical manifestations, and a surgical approach tailored to the
condition of individual patients is recommended.
Keywords: esophageal tracheobronchial fistula, surgery, safety